Muscle-type nicotinic acetylcholine receptor (fetal) (fetal nAChR)

The fetal muscle-type nicotinic acetylcholine receptor (nAChR) is a pentameric ligand-gated ion channel composed of two α1 subunits and one each of the β1, γ, and δ subunits (UniProt P02708, P11230, P07510, Q07001). It is primarily expressed during embryonic development at the neuromuscular junction, where it mediates the response to acetylcholine released from motor neurons, leading to muscle contraction (StatPearls, Physiology, Nicotinic Receptor). In late gestation or early postnatal life, the γ subunit is typically replaced by the ε subunit to form the adult receptor (α1βδε). Mutations in the subunits of the fetal receptor, particularly the γ subunit (CHRNG), are associated with Escobar syndrome and Fetal Akinesia Deformation Sequence (FADS), characterized by reduced fetal movement and developmental abnormalities (Hoffman et al., 2006, PubMed: 17054359). This receptor is a target for various neuromuscular blocking agents used in anesthesia, which can act as either depolarizing or non-depolarizing blockers to induce muscle relaxation (PubChem, Acetylcholine). Notably, the fetal isoform can be re-expressed in adult muscle following denervation or during certain pathological states, which has significant implications for the sensitivity to muscle relaxants like succinylcholine (NIH, Congenital Myasthenic Syndromes).

Other names

Embryonic nicotinic acetylcholine receptorα1βγδ nAChRNicotinic acetylcholine receptor alpha-1 beta-1 gamma deltaMuscle nAChR fetal isoform

Ligand-gated ion channel agonism or antagonism at the neuromuscular junction, where binding of acetylcholine or agonists triggers channel opening and cation influx, while antagonists block this process to prevent muscle contraction.